Target intelligence / Profile preview

DNA topoisomerase 1–DNA cleavable complex (Top1cc) (Top1cc)

Target
Top1cc
Molecular classification
Enzyme-DNA complex, DNA topoisomerase, Isomerase
01

Overview

The DNA topoisomerase 1–DNA cleavable complex (Top1cc) is a transient catalytic intermediate formed when the enzyme DNA topoisomerase 1 (Top1) nicks a single strand of DNA to relieve torsional strain during replication and transcription (Pommier, Nat Rev Cancer, 2006; Champoux, Annu Rev Biochem, 2001). In this state, the enzyme is covalently linked to the 3' phosphate end of the DNA via a tyrosyl-DNA phosphodiester bond (Pommier et al., Chem Rev, 2016). This complex is the primary molecular target for camptothecin-derived chemotherapeutic agents, which act as interfacial inhibitors by binding at the site of the DNA cleavage (Pommier, Nat Rev Cancer, 2006). By stabilizing the Top1cc, these drugs prevent the religation of the DNA strand, effectively trapping the enzyme on the DNA (Pommier et al., Chem Rev, 2016). When advancing replication forks or transcription complexes collide with these trapped Top1ccs, they are converted into lethal double-strand breaks, triggering apoptosis (Thomas et al., Clin Cancer Res, 2017). This mechanism makes Top1cc a critical target in the treatment of various malignancies, including colorectal and small cell lung cancers (Pommier, Nat Rev Cancer, 2006).

Other names
DNA topoisomerase I–DNA cleavable complexTop1-DNA covalent complexTopoisomerase I cleavage complexTop1-DNA complexTop1-DNA covalent intermediate
02

Mechanism of action

Stabilization of the transient covalent Top1-DNA complex, inhibiting DNA religation and causing replication-mediated DNA damage.

03

Biological functions

DNA replicationTranscriptionDNA relaxationChromatin remodelingDNA repair
04

Disease associations

CancerColorectal cancerOvarian cancerSmall cell lung cancerBreast cancer
05

Safety considerations

MyelosuppressionSevere diarrheaNeutropeniaGastrointestinal toxicity
06

Interacting drugs

Irinotecan

7 more in the full profile.

07

Biomarkers

TOP1 expressionSLFN11 (Schlafen 11)TDP1 (Tyrosyl-DNA phosphodiesterase 1) activityPTEN status

Beyond the preview

Go deeper on DNA topoisomerase 1–DNA cleavable complex (Top1cc) (Top1cc).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA topoisomerase 1–DNA cleavable complex (Top1cc) (Top1cc).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call